Gal Bitan


Gal Bitan got a PhD in organic chemistry from the Hebrew University of Jerusalem, Israel, followed by postdoctoral training at Beth Israel-Deaconess Medical Center/Harvard Medical School and Brigham and Women's Hospital/Harvard Medical School, Boston, MA. Dr. Bitan has made fundamental contributions to the study of early events in the pathologic cascades that cause Alzheimer's disease and discovered one of the earliest oligomers in the assembly cascade of amyloid β-protein, the paranucleus. In 2004, Dr. Bitan joined UCLA where he is currently a Professor of Neurology in the David Geffen School of Medicine. His research program includes basic research on the factors controlling formation of neurotoxic oligomers in different neurodegenerative diseases, and development of novel drug candidates and biomarkers for these diseases.

Pre Publication Reviews

Showing of  

Your statistics are calculated based on the information you have submitted to Publons.
Read more about them here.

Compare your statistics to those of any research field on Publons using the form below. Leaving the form blank will compare your statistics to all research fields on Publons.



Reviews (last 12 months)


Reviews (average per year)






Journal Impact Factors of journals reviewed for

The distribution of the Journal Impact Factors of journals Gal Bitan has reviewed for.

Gal Bitan

All fields reviewers

Total reviews over time

A cumulative record of Gal Bitan's total number of reviews.

Reviews per month

The total number of reviews performed by Gal Bitan each month.

Average review length

The average number of words per review compared to the average of All fields reviewers and the average of reviewers at affiliated institutions.

Note: only reviews with associated content are included in the graph below and where content is present we can not guarantee that it is complete or truly the content of the review.

Weekly review punchcard

The distribution of days that reviews were performed on, compared to All fields reviewers and reviewers at affiliated institutions.